Myomectomy during pregnancy: A systematic review.

Eur J Obstet Gynecol Reprod Biol

Third Department of Obstetrics and Gynecology, Ippokrateio Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos 49, Thessaloniki, Greece.

Published: November 2020

Objective: Uterine fibroids affect 2-10 % of pregnant women. Although usually asymptomatic, they may be associated with pregnancy complications. Myomectomy is preferably avoided antenatally, however, it has been reported in symptomatic cases that did not respond to conservative management. The aim of this study was to summarize the published literature and present the reported outcomes and associated risks of this procedure.

Study Design: A systematic research of the literature was conducted in PubMed/MEDLINE, Scopus and the Cochrane Library, including case reports and case series. An effort was made to numerically analyse all parameters included in the case reports.

Results: Overall, 54 relevant articles were identified, including 97 patients. The median gestational age at diagnosis was 13 (range 6-26) weeks, while the median age at myomectomy was 16 (range 6-26) weeks. Abdominal pain, not responding to medical treatment was the most common indication for surgery. The median number of fibroids removed per patient was one (range 1-5). Most of them were subserous pedunculated or subserous and fundal. Laparotomy (78.4 %) was the principal surgical approach, however, laparoscopic and vaginal operations were also reported. The median duration of surgery was 53 (range 20-150) min. The histopathology revealed necrosis and degeneration as the main findings of removed fibroids. The pregnancy outcome was favourable in most of the cases, with few complications reported.

Conclusion: Based on the limited published data, myomectomy during pregnancy appears as a safe procedure in cases of symptomatic uterine fibroids not responding to conservative management and therefore it may be considered, following appropriate counselling regarding the associated risks.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejogrb.2020.08.018DOI Listing

Publication Analysis

Top Keywords

myomectomy pregnancy
8
uterine fibroids
8
conservative management
8
associated risks
8
range 6-26
8
6-26 weeks
8
myomectomy
4
pregnancy systematic
4
systematic review
4
review objective
4

Similar Publications

Uterine cystic adenomyosis: a case report.

AME Case Rep

December 2024

Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Background: Uterine cystic adenomyosis (CA) is a unique form of adenomyosis with a single or fused lumen of the cystic space exceeding a diameter of 1 cm that typically results in progressively worsening dysmenorrhea. In most cases, the prognosis and pregnancy outcomes of CA remained unclear, and therefore further studies are warranted.

Case Description: A 19‑year‑old woman was admitted for irregular vaginal bleeding that lasted for more than one month.

View Article and Find Full Text PDF

Objective: Hysteroscopic myomectomy is widely regarded as safe and feasible, although achieving single-session results for larger myomas often requires alternative methods. This study introduces a novel approach: ultrasound-guided myoma extirpation using ring forceps combined with hysteroscopy.

Methods: This retrospective, single-center study includes patients who underwent ultrasound-guided myoma extirpation between 2016 and 2024.

View Article and Find Full Text PDF

Pregnancy Outcomes After Transvaginal Radiofrequency Ablation of Leiomyomas.

Obstet Gynecol

January 2025

Division of Minimally Invasive Surgery, Victoria Rey Clinic, Loyola University, Seville, Spain.

Objective: To evaluate pregnancy outcomes after transvaginal radiofrequency ablation of leiomyomas.

Methods: We conducted a retrospective review of the medical records of 226 pregnant patients after transvaginal radiofrequency ablation of leiomyomas from January 1, 2017, to February 28, 2022.

Results: Patients' mean age was 37.

View Article and Find Full Text PDF

Background: Placenta accreta spectrum (PAS) disorder is a fatal condition responsible for obstetric haemorrhage, which contributes to increased feto-maternal morbidity and mortality. The main contributing factor is a scarred uterus, often from a previous cesarean delivery, myomectomy, or uterine instrumentation. The occurrence of PAS in an unscarred uterus is extremely rare, with only anecdotal cases reported so far in the literature.

View Article and Find Full Text PDF

Objective: To demonstrate the "cold loop technique" for the hysteroscopic treatment of International Federation of Gynaecology and Obstetrics (FIGO) type 3 myomas.

Design: Step-by-step demonstration of the technique using educative video.

Subjects: A 45-year-old patient with infertility with repeated oocyte donor in vitro fertilization failures affected by a FIGO type 3 myoma.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!